Hear directly from members of our community on their journeys with macular disease.
Eye injections have helped Elisabeth maintain her sight. But the proposed cut to the Medicare rebate for this life-changing treatment would make it too expensive for 47,000 Australian patients. That gives us 47,000 Reasons to oppose the cut.
Welcome to the latest edition of Vision Voice.
Statement from Dr Kathy Chapman, CEO, Macular Disease Foundation Australia
By The Hon. Jillian Skinner, AM, former NSW Minister for Health. This article was originally published by News Corp.
Macular Disease Foundation Australia calls on next Federal Government to bulk-bill sight-saving eye injections for pensioners.
We have released new research in collaboration with the University of New South Wales which has revealed the median total cost for people living with macular disease, who also receive sight-saving eye injections, is 12 percent* ($3,621) of the annual government pension payment.
The Therapeutic Goods Administration (TGA) approval of the new eye injection treatment pegcetacoplan (SYFOVRE®) is welcome news, as it will give many people with Geographic Atrophy a treatment option that they’ve never had before to slow the progression of the disease.
Welcome to the latest edition of Vision Voice.
National peak body Macular Disease Foundation Australia (MDFA) has launched Eye Connect – Australia’s first
MDFA has received a positive response from the people participating in our new Eye Connect support service.
